Lecturio Acquires SimTutor to Expand its Digital Healthcare Training Portfolio

NEW YORK, Oct. 20, 2025 /PRNewswire/ — Lecturio, the global digital healthcare education company, announced today the acquisition of SimTutor, a leading provider of interactive simulation-based tools. This acquisition further strengthens Lecturio’s portfolio of solutions that enable experiential, skills-based learning for healthcare professions worldwide.

SimTutor’s flagship products, SIMTICS and SimTutor Author, enable learners to safely practice and master clinical and procedural skills through interactive online simulations. The company’s training approach combines cognitive learning with hands-on practice to support clinical education. With more than 200 ready-to-use simulations, SimTutor supports a wide range of healthcare disciplines including medical and dental assisting, radiography, and other allied health programs covering areas such as respiratory care, phlebotomy, infection control, EKG/ECG, basic life support & more. Educational institutions and healthcare organizations around the world use SimTutor’s products to enhance both classroom and clinical training.

This deal follows Lecturio’s 2024 acquisition of Healer from NEJM Group®, publisher of the New England Journal of Medicine, furthering its goal of providing comprehensive learning experiences from foundational knowledge to practice.

“By welcoming SimTutor into the Lecturio portfolio, we are advancing our mission to provide a complete learning experience that supports both the knowledge and practical aspects of clinical education,” said Stefan Wisbauer, Co-CEO of Lecturio.SimTutor brings valuable simulation-based practice and assessment to our global audience of educators and learners.”

“We are thrilled to join Lecturio’s global education network,” said Guy Harrington, CEO and Director of SimTutor. Our shared vision of improving healthcare education through accessible, high-quality learning tools will drive the next phase of innovation in simulation and skills training.”

With SimTutor’s simulation technologies now part of its offering, Lecturio continues to expand its capabilities in digital clinical education by bridging foundational learning, clinical reasoning, and applied skills training.

About Lecturio
Lecturio is a leading online learning platform offering a wide range of courses and resources for medical and nursing students, clinicians, healthcare professionals, and institutions such as medical schools, nursing schools and hospitals. As an AI-enhanced precision medical education platform, Lecturio streamlines teaching, boosts efficiency, and empowers both learners and educators to achieve better outcomes. For more information, visit www.lecturio.com/inst.

About SimTutor
SimTutor is a provider of  simulation-based learning tools that make training more interactive, measurable, and accessible. Its products, SIMTICS and SimTutor Author, are used worldwide in education and workforce training to help people gain hands-on practice with new skills in a safe online environment. For more information, visit www.simtutor.com.

Contact Information
Remy Schneider
+1 402 301 3232
institutions@lecturio.com
 www.lecturio.com/inst

Logo – https://mma.prnewswire.com/media/2686281/5569066/Lecturio_Logo.jpg

View original content to download multimedia:https://www.prnewswire.com/news-releases/lecturio-acquires-simtutor-to-expand-its-digital-healthcare-training-portfolio-302587622.html

SOURCE Lecturio GmbH

Staff

Recent Posts

TempraMed Launches New Product, VIVI Cap Smart, Expanding Its Portfolio to Include a Digital Health Offering

Integrated smart technology builds on TempraMed's proven VIVI platform, providing robust Temperature control with medication…

3 hours ago

More Than a Meal Plan: The Clinical Impact of a Kidney Dietitian

NORTHAMPTON, MA / ACCESS Newswire / December 26, 2025 / Specialized nutrition experts are key…

5 hours ago

President Trump’s Executive Marijuana Action Exposes the Truth-How the DEA Delayed Medicine While Protecting Everything Else

"Despite clear congressional mandates and FDA authorization, the Drug Enforcement Administration failed to act within…

5 hours ago

From Follower to Force: China’s Biotech Sector Enters the Global Clinical Mainstream

WASHINGTON, Dec. 26, 2025 /PRNewswire/ -- Over the past decade, China has evolved from a biotechnology…

8 hours ago

Aptevo Therapeutics Announces 1-for-18 Reverse Stock Split

SEATTLE, WA / ACCESS Newswire / December 26, 2025 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a…

11 hours ago